Paul Charifson is a seasoned expert in molecular design and medicinal chemistry, bringing over 30 years of experience to the field. His extensive career spans significant industry roles at leading companies such as Vertex Pharmaceuticals, GlaxoSmithKline (GSK), and Cray Research.

Charifson earned his PhD in Medicinal Chemistry from the University of North Carolina at Chapel Hill. Throughout his career, he has leveraged his expertise to advance the design and optimization of therapeutic molecules, playing a key role in various stages of drug discovery and early development.